VYNE Therapeutics Inc.

Nasdaq:VYNE

Pharmaceutical Preparations·BRIDGEWATER, NJ

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	2/27/26	→
10-Q	Q3 2025	9/30/25	11/6/25	→
10-Q	Q2 2025	6/30/25	8/14/25	→
10-Q	Q1 2025	3/31/25	5/8/25	→
10-K	FY 2024	12/31/24	3/6/25	→
10-Q	Q3 2024	9/30/24	11/7/24	→
↓

Earnings Releases (8-K)

26 shown

Filed	Period
11/6/25	Q4 FY2025	→
8/14/25	Q3 FY2025	→
7/30/25	Q2 FY2025	→
5/8/25	Q2 FY2025	→
3/6/25	Q1 FY2025	→
11/7/24	Q4 FY2024	→
↓

News (8-K)

54 shown

Filed	Type	Description
3/11/26	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
1/30/26	Agreement	Entry into a Material Definitive Agreement	→
12/17/25	Ctrl Change	Entry into a Material Definitive Agreement	→
12/12/25	Vote	Submission of Matters to a Vote of Security Holders	→
9/12/25	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
1/13/25	Other	Other Events	→
↓

Prospectuses & Registrations

31 shown

Filed	Form	Description
11/12/25	ARS	ARS	→
12/19/24	S-8	S-8	→
11/12/24	ARS	ARS	→
3/1/24	S-3	S-3	→
3/1/24	S-8	S-8	→
12/13/23	S-8	S-8	→
↓

Filing History(608 filings)

TypeDateAccessionPeriodSize

8-K

Mar 11, 2026

0001104659-26-026439FORM 8-K

Mar 11, 2026

185.7 KB

10-K

Feb 27, 2026

0001566044-26-00000210-K

Dec 31, 2025

8.2 MB

425

Jan 30, 2026

0001104659-26-008646425

—

152.1 KB

8-K

Jan 30, 2026

0001104659-26-008642FORM 8-K

Jan 30, 2026

349.1 KB

Jan 5, 2026

0001727794-26-000002

Dec 31, 2025

5.0 KB

Jan 5, 2026

0001867033-26-000002

Dec 31, 2025

5.0 KB

Jan 5, 2026

0001727756-26-000002

Dec 31, 2025

5.0 KB

Jan 5, 2026

0001727809-26-000002

Dec 31, 2025

5.0 KB

425

Dec 17, 2025

0001104659-25-121829425

—

1.4 MB

8-K

Dec 17, 2025

0001104659-25-121828FORM 8-K

Dec 17, 2025

1.9 MB

Dec 15, 2025

0001632295-25-000005

Dec 12, 2025

5.8 KB

Dec 15, 2025

0001055404-25-000004

Dec 12, 2025

5.6 KB

Dec 15, 2025

0001417397-25-000004

Dec 12, 2025

5.6 KB

Dec 15, 2025

0001240499-25-000004

Dec 12, 2025

5.7 KB

8-K

Dec 12, 2025

0001104659-25-120637FORM 8-K

Dec 12, 2025

195.2 KB

SCHEDULE 13G/A

Nov 14, 2025

0001104659-25-112496

—

18.0 KB

SCHEDULE 13G/A

Nov 14, 2025

0001580642-25-007308

—

11.5 KB

SCHEDULE 13G/A

Nov 14, 2025

0001172661-25-004954

—

10.0 KB

ARS

Nov 12, 2025

0001104659-25-110373ARS

Dec 31, 2024

780.7 KB

DEF 14A

Nov 12, 2025

0001104659-25-110346DEF 14A

Dec 12, 2025

2.3 MB

10-Q

Nov 6, 2025

0001566044-25-00001010-Q

Sep 30, 2025

830.0 KB

8-K

Nov 6, 2025

0001566044-25-0000078-K

Nov 6, 2025

281.8 KB

Oct 2, 2025

0001867033-25-000003

Sep 30, 2025

5.0 KB

Oct 2, 2025

0001727756-25-000003

Sep 30, 2025

5.0 KB

Oct 2, 2025

0001727809-25-000003

Sep 30, 2025

5.0 KB

25 filings shown

VYNE Therapeutics Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(608 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
1/5/26	4	4	→
1/5/26	4	4	→
1/5/26	4	4	→
1/5/26	4	4	→
12/15/25	4	4	→
12/15/25	4	4	→
↓

Filed	Form	Description
1/30/26	425	425	→
12/17/25	425	425	→
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
8/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
↓